drugset / Trial / NCT04621461

Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting

NCT04621461

Phase 4 Completed 3 enrolled St. Francis Hospital, New York
RandomizedSingle-groupDouble-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled trial to assess the efficacy of zinc in a higher risk COVID-19 positive outpatient population.

Timeline

Start
2020-12-20
Primary completion
2021-02-08
Completion
2021-02-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Zinc Sulfate Unknown 220 mg

Indications